U.K.’s Medicines and Healthcare Products Regulatory Agency Authorizes Molnupiravir for the Treatment of Mild-to-Moderate COVID-19 in Adults With a Positive SARS-CoV-2 Diagnostic Test and Who Have at Least One Risk… Read More
We are also pleased to announce our 2022 funding competition schedule. Michael Smith Health Research BC’s Scholar and Research Trainee awards provide funding to support BC’s next generation of health… Read More
Presentation will highlight the development of functional 3D bioprinted co-cultured human hepatocyte spheroids for use as a liver tissue therapeutic VANCOUVER, BC – Aspect Biosystems, a biotechnology company pioneering the… Read More
Patent covers novel effects for neurodegenerative diseases Expands InMed’s patent portfolio with incremental rare cannabinoid VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in… Read More
VANCOUVER, BC – AbCellera (Nasdaq: ABCL) today announced an additional purchase by the U.S. government from Eli Lilly and Company (Lilly) for bamlanivimab with etesevimab for administration together. This neutralizing antibody… Read More
